MSB 11.8% $1.57 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-826

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 12,424 Posts.
    lightbulb Created with Sketch. 1114
    Hi Stockrock,
    I think its good to have the discussion but truth is, your either in or your out come announcement.

    Stockrock you got yourself in a bit of a state prior to the panel meeting.
    Where you got a twitchy on holding.

    My view is theres no profit in anymore thinking about it.

    I just trust the MSB team and the science.

    Be positive and it will happen.

    Aloha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.57
Change
-0.210(11.8%)
Mkt cap ! $1.792B
Open High Low Value Volume
$1.72 $1.74 $1.52 $15.63M 9.716M

Buyers (Bids)

No. Vol. Price($)
1 5127 $1.57
 

Sellers (Offers)

Price($) Vol. No.
$1.57 39613 3
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.